Jason Drew Smith - 31 Aug 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role: General Counsel
Signature: /s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol: URGN
Transactions as of: 31 Aug 2022
Net transactions value: -$25,999
Form type: 4
Filing time: 02 Sep 2022, 11:40:01 UTC
Previous filing: 02 Feb 2022
Next filing: 02 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	URGN	Ordinary Shares	Options Exercise		+8,333	+112%		15,782	31 Aug 2022	Direct	F1
transaction	URGN	Ordinary Shares	Sale	$25,999	-3,606	-23%	$7.21	12,176	31 Aug 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	URGN	Restricted Stock Units	Options Exercise	$0	-8,333	-50%	$0.000000	8,334	31 Aug 2022	Ordinary Shares	8,333		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
F2	Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
F3	The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vest in three equal annual installments on November 30, 2021, August 31, 2022 and August 31, 2023.